Toggle navigation
Cialis
Cialis Daily
Viagra
Kamagra
Priligy
About Us
Join Our Team
Our Programs
Our Pipeline
Our Science
Scientific Presentations
HOTSHOT
Products
Generic Cialis
Generic Viagra
Cialis Daily
Cialis Professional
Cialis Soft
Cialis Super Active
Viagra Super Active
Viagra Professional
Viagra Oral Jelly
Cenforce
Fildena
Sildalis
Lovegra
Kamagra
Kamagra Oral Jelly
Kamagra Chewable
Kamagra Gold
Super Kamagra
Malegra FXT
Priligy
Super P Force
Super Avana
Extra Super Avana
Extra Super P Force
SCIENTIFIC PRESENTATIONS
AAN: American Academy of Neurology Annual Meeting
April 2017 | Boston, MA
Chemical Neuro Stimulation by FLX-787, a co-activator of TRPA1/TRPV1, for the Potential Treatment of Cramps, Spasms and Spasticity
ASENT: American Society for Experimental NeuroTherapeutics
March 2017 | Rockville, MD
Human Efficacy of FLX-787, a Dual Activator of TRPV1 and TRPA1 Ion Channels, Reducing Muscle Cramp Frequency and Pain in Randomized Controlled Studies
ACTRIMS: Americas Committee for Treatment and Research in Multiple Sclerosis
February 2017 | Orlando FL
Flex-201: A Multicenter, Randomized, Blinded Study to Evaluate the Efficacy and Tolerability of FLX-787 in MS
SFN: Society for Neuroscience
November 2016 | San Diego, CA
Chemical Neuro Stimulation of TRPV1 and TRPA1 Sensory Neurons Decreases Muscle Cramps in Humans
ASENT: American Society for Experimental NeuroTherapeutics
March 2016 | Bethesda, MA
Synthetic Transient Receptor Potential (TRP) Ion Channel Activators Demonstrate Efficacy in Preventing Human Muscle Cramping: A Potential New Drug Treatment for Muscle Cramps and Spasticity
ACSM: American College of Sports Medicine Annual Meeting
June 2016 | Boston, MA
Etiology and Treatment of Exercise-Associated Muscle Cramps: Emerging Research
AAN: American Academy of Neurology Annual Meeting
April 2016 | Vancouver, BC
Orally-administered TRPV1 and TRPA1 Activators Reduce Night Leg Cramps in a Randomized, Blinded, Placebo-Controlled, Crossover Human Trial
ALS/MND: 26th International Symposium on Amyotrophic Lateral Sclerosis/Motor Neuron Disease
December 2015 | Orlando, FL
TRPV1 and TRPA1 Activators Reduce Human Muscle Cramping: A Potential New Treatment for ALS Symptoms
SFN: Society for Neuroscience Annual Meeting
October 2015 | Chicago, IL
TRPV1 and TRPA1 Activators Reduce Human Muscle Cramping
ECTRIMS: 21st Congress of the European Committee for Treatment and Research in Multiple Sclerosis
October 2015 | Barcelona, Spain
TRPV1 and TRPA1 Activators Reduce Muscle Cramping: A Potential New Treatment for MS Symptoms
AAN: American Academy of Neurology Annual Meeting
April 2015 | Washington, DC
Afferent sensory input by orally-administered TRPV1 and TRPA1 activators inhibits electrically-induced muscle cramps in normal healthy volunteers
